advertisement

WGA Rescources

Pensyl D 1

Showing records 1 to 1 | Display all abstracts from Pensyl D

26671 Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations
Sullivan-Mee M; Pensyl D; Alldredge B; Halverson K; Gerhardt G; Qualls C
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 355-360

Issue 12-3

Change Issue


advertisement

Oculus